Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
42,998,448
-
Total 13F shares
-
49,919,475
-
Share change
-
-979,718
-
Total reported value
-
$940,553,299
-
Put/Call ratio
-
9.7%
-
Price per share
-
$18.84
-
Number of holders
-
228
-
Value change
-
-$11,898,336
-
Number of buys
-
106
-
Number of sells
-
114
Institutional Holders of Pacira BioSciences, Inc. - Common Stock, par value $0.001 per share (PCRX) as of Q4 2024
As of 31 Dec 2024,
Pacira BioSciences, Inc. - Common Stock, par value $0.001 per share (PCRX) was held by
228 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
49,919,475 shares.
The largest 10 holders included
BlackRock, Inc., VANGUARD GROUP INC, Pacer Advisors, Inc., D. E. Shaw & Co., Inc., RENAISSANCE TECHNOLOGIES LLC, STATE STREET CORP, DIMENSIONAL FUND ADVISORS LP, Doma Perpetual Capital Management LLC, MILLENNIUM MANAGEMENT LLC, and UBS Group AG.
This page lists
229
institutional shareholders reporting positions in this security
for the Q4 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.